UnitedHealth Group (UNH) gave investors the kind of quarter they had been waiting to see. The company reported first-quarter 2026 revenue of $111.7 billion, up 2% from a year earlier, along with earnings of $6.90 per share and adjusted earnings of $7.23 per share. It also raised its full-year 2026 outlook to more than $17.35 in earnings per share and more than $18.25 in adjusted earnings per share.
The reaction was strong because the company had spent months trying to convince investors that its cleanup efforts were beginning to take hold. Same-day market coverage said the stock jumped more than 8% after the report as investors responded to the earnings beat and the higher full-year view. Reuters also reported that profit and revenue both came in ahead of Wall Street expectations.
The cost picture gave investors the clearest relief
The medical care ratio played a big part in the release. UnitedHealth said the ratio was 83.9% in the first quarter, down from 84.8% a year earlier. The company said the year-over-year improvement reflected stronger medical cost management and favorable reserve development, even with utilization and unit-cost trends still running high.
UnitedHealth has been dealing with pressure from higher care utilization, cost uncertainty, and broader concerns around execution. Reuters said the lower medical-cost ratio came in better than analysts expected and helped support the rally in the shares.
The quarter still had mixed spots under the surface
The report was not perfect, but it was strong enough in the right areas. UnitedHealthcare revenue rose 4% to $86.2 billion, while Optum Rx revenue increased 2% to $35.7 billion. Optum Health revenue, however, slipped 3% to $24.1 billion, and Optum Insight revenue was roughly flat at $5.1 billion.
More United Health
- Is UnitedHealth a safe dividend stock after Medicare shock?
- Why a $1.2 trillion Medicare Advantage overpayment matters to you
- UNH stock just did something to the Dow Jones you rarely see
Some parts of the company are still working through slower growth and operational changes, but the broader result was good enough to make those issues look manageable rather than dominant. Management also said actions taken over the last several quarters are helping strengthen operations, improve the consumer and provider experience, and modernize the business.
UnitedHealth by the numbers
- First-quarter 2026 revenue: $111.7 billion, up 2% year over year
- First-quarter earnings per share: $6.90
- First-quarter adjusted EPS: $7.23
- Full-year 2026 EPS outlook: more than $17.35
- Full-year 2026 adjusted EPS outlook: more than $18.25
- Medical care ratio: 83.9%, down from 84.8% a year ago
- Cash flow from operations: $8.9 billion
- Debt-to-capital ratio: 42.9% as of March 31, 2026
Bloomberg via Getty Images
Management is trying to turn a reset into a stronger 2026 story
UnitedHealth’s January outlook had already pointed to a better 2026, but the first-quarter report moved that story forward. Back in January, the company guided to more than $17.10 in earnings per share and more than $17.75 in adjusted earnings per share for 2026. The new forecast lifts both targets and gives management a stronger claim that the company’s reset is showing up in reported numbers.
The company’s own language reflects that effort. CEO Stephen Hemsley said UnitedHealth is continuing to simplify and modernize health care while bringing more value, affordability, transparency, and connectivity to consumers and providers. Those are broad ambitions, but the quarter gave investors something more concrete to work with: stronger earnings, a lower medical care ratio, and a higher full-year outlook.
The stock is back to trading on execution
UnitedHealth still has work to do, especially across the more uneven parts of Optum. But the first-quarter report gave the market a cleaner read on where the company is improving and why investors were willing to pay more for the stock after the release. The move higher beat estimates, but it also made the recovery look more credible.
That leaves the next question, where it usually belongs with UnitedHealth: on execution. The company raised guidance, managed costs better, and gave investors a quarter that looked steadier than the headline worries surrounding the business. For now, that was enough to shift the tone around the stock in a better direction.
Related: Morgan Stanley names UnitedHealth a “Top Pick”
